Canopy Growth Corporation (CGC)
NASDAQ: CGCHealth Care Medicinal Chemicals and Botanical Products USD
Market open · Delayed 15 min · as of Oct 8, 12:11 PM ET
CGC stock chart
Technical analysisKey statistics
All statistics- Market cap
- $370.90M
- EPS (TTM)
- -$0.45
- Dividend yield
- None
- 52-week range
- 0.81 – 2.38
- Day range
- 0.81 – 0.8788
- Volume / Avg
- 2.39M / 2.75M
- Beta
- —
- Shares outstanding
- 423.04M
- Next earnings
- Nov 6, 2026
52-week range
CGC stock today
Shares of Canopy Growth (CGC) are trading lower on Oct 8 at $0.8255, a drop of 5.82% or $0.051 per share, versus the S&P 500's 0.35% decline. Shares are 65.3% below their 52-week high of $2.38, set on Dec 18, 2025 and 1.9% above the 52-week low of $0.81, near the bottom of the past year's range. CGC is down 23.1% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 39.6%.
Canopy Growth has posted a net loss over the last twelve months (EPS of -$0.45), so its P/E ratio is not meaningful. Canopy Growth's next earnings report is expected on Nov 6, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Canopy Growth
Company profileCanopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and internationally. The company operates through two segments, Cannabis and Storz & Bickel. It also provides vaporizers and accessories; dried flower and pre-rolled joints, oil, and vapes and beverages; extracts and concentrates, such as softgel capsules; and cannabis edibles, including gummies.
- Sector
- Health Care
- Industry
- Medicinal Chemicals and Botanical Products
- CEO
- Mr. Luc Mongeau
- Headquarters
- Smiths Falls, ON
- Employees
- 1,128
- Website
- canopygrowth.com
Analyst forecast
ForecastConsensus (8 analysts)
none
Avg. price target
$1.19+44.16%
- Strong buy 0
- Buy 2
- Hold 6
- Sell 0
- Strong sell 0
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 6, 2026
- EPS estimate
- $-0.03
Canopy Growth peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| GLASGlass House Brands Inc. Subordinate Voting Shares | 4.65 | -9.36% | $438.23M | vs CGC |
| OBIOOrchestra BioMed Holdings Inc. | 5.67 | +0.18% | $340.80M | vs CGC |
| SNDLSNDL Inc. | 1.24 | -1.20% | $303.96M | vs CGC |
| ACBAurora Cannabis Inc. | 4.42 | -1.01% | $279.51M | vs CGC |
| TLRYTilray Brands Inc. | 3.48 | -6.40% | $513.87M | vs CGC |
| USNAUSANA Health Sciences Inc. | 14.40 | -1.84% | $266.06M | vs CGC |
| NAGENiagen Bioscience Inc. | 2.61 | -4.04% | $206.52M | vs CGC |
| MDWDMediWound Ltd. | 12.48 | -2.88% | $161.12M | vs CGC |
Indexes, lists and sector
Canopy Growth stock FAQ
What is Canopy Growth's stock price today?
CGC last traded at $0.8255 as of Oct 8, 12:11 PM EDT, down 5.82% on the day. Prices are delayed at least 15 minutes.
Does Canopy Growth pay a dividend?
No. Canopy Growth does not currently pay a regular cash dividend.
When is Canopy Growth's next earnings date?
Canopy Growth is expected to report earnings on Friday, November 6, 2026. Analysts expect EPS of $-0.03.
Who is Canopy Growth's CEO?
Mr. Luc Mongeau is the chief executive officer of Canopy Growth Corporation, which has about 1,128 employees.
Has CGC ever split its stock?
Yes. The most recent CGC stock split was a 1-for-10 split on Dec 20, 2023.
What is the CGC 52-week high?
The 52-week high for CGC is $2.38 and the 52-week low is $0.81. The stock is currently 65.3% below its high.